MP1032 Treatment in Patients With Moderate to Severe COVID-19
Clinical trial NCT04932941 · COMPLETED
Trial details
- NCT number
- NCT04932941
- Sponsor
- MetrioPharm AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2022-07-28
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.